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Abstract Mitochondrial fusion is a poorly characterized pro-
cess which has mainly been studied in yeast and Drosophila but
is thought to occur in all eukaryotes. Until now, there was only
indirect evidence to support such a process in mammalian cells.
In this study, using a cell fusion system, we found that mito-
chondrial fusion occurs rapidly in mammalian cells and is com-
pleted in less than 24 h. We report that the fusion of mitochon-
dria requires an intact mitochondrial inner membrane potential
but is independent of a functional cytoskeleton.
# 2003 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
Mitochondria are complex semi-autonomous organelles
surrounded by a double membrane and have their own ge-
nome and protein synthesis machinery. They perform a vari-
ety of important functions including reactions of the tri-
carboxylic acid cycle, oxidative phosphorylation and ATP
production. Moreover, they are key players in the cascade
that leads to apoptosis [1^4].
In recent years, the view of mitochondrial morphology has
changed from that of individual organelles anchored on the
cell’s cytoskeleton to a dynamic and organized network of
tubule-like mitochondria. This network maintains its shape
by movement, ¢ssion and fusion. Mitochondrial dynamics
has been extensively studied in yeast [5]. Among the proteins
that control the ¢ssion in mammals are dynamin-related pro-
tein 1 (Drp1, ¢rst identi¢ed as Dnm1p in yeast) and Fis1p [6].
Fission of mitochondria also appears to be involved in di¡er-
ent cellular events including apoptosis [2,7]. The machinery of
mitochondrial fusion is less well characterized although a few
proteins have now been shown to play a role in this event [8].
During Drosophila melanogaster spermatogenesis, mitochon-
dria in spermatids aggregate, fuse, and elongate beside the
growing £agella. Investigation of this process permitted the
identi¢cation of the fuzzy onions (fzo) gene that encodes a
transmembrane GTPase necessary for mitochondrial fusion.
Fzo mutant males are defective in this developmentally regu-
lated mitochondrial fusion and are sterile [9]. Fzo has homo-
logues in mammals, nematodes, and yeast. The yeast homo-
logue was characterized [10] and shown to be required for
mitochondrial fusion [11]. Inhibition of mitochondrial fusion
in yeast results in loss of mitochondrial DNA, and a frag-
mented mitochondrial morphology. This could be suppressed
by a compensatory mutation in the ¢ssion machinery protein
Dnm1p [12,13]. A genetic screen based on this ¢nding was
used to identify a new component required for mitochondrial
fusion, Ugo1 [12]. In mammals, mitofusin 1 (Mfn1) and mi-
tofusin 2 (Mfn2) were found to be homologous to Fzo1p [14]
but in contrast to Drosophila Fzo, they are ubiquitously ex-
pressed [15]. However, their ability to drive mitochondrial
fusion is unclear [14,15].
Up to now, evidence for mitochondrial fusion in mammals
has been provided by light and electron microscopy studies
(for a extended review see [16]), complementation studies both
in cells [17^21] and in vivo in mice [22]. The results from those
studies are in part contradictory, some studies showing com-
plementation between fused mitochondria using respiration-
competent and respiration-de¢cient mitochondria [17,18,21]
whilst others demonstrated a lack of complementation [19]
or very rare events [20]. So could mammalian mitochondria
merge? Here, using a cell fusion assay, we show that mamma-
lian mitochondria do fuse and that this process occurs within
less than 2 h. Mitochondrial fusion requires an intact mito-
chondrial inner membrane potential but does not rely on the
cytoskeleton. Co-transfection with human hFis1 protein or a
dominant negative mutant of human Drp1 also suggests that
mitochondrial fusion is independent of its complementary
process, ¢ssion.
2. Materials and methods
2.1. Materials
Dulbecco’s modi¢ed Eagle’s medium high glucose (DMEM high
glucose), fetal calf serum, glutamine, penicillin, streptomycin, tetracy-
cline, nocodazole, cytochalasin D, cycloheximide, TRITC-phalloidin
and carbonyl cyanide m-chlorophenyl hydrazone (cccp) were pur-
chased from Sigma (St. Louis, MO, USA). G418 was purchased
from Promega (Catalys, Switzerland) and hygromycin from Calbio-
chem (Juro, Switzerland). Fugene was purchased from Roche (Roche,
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Switzerland), tetramethyl rhodamine (TMRE) and taxol (paclitaxel)
from Molecular Probes (Eugene, OR, USA) and the caspase inhibitor
zVAD was from Enzyme Systems Products (Livermore, CA, USA).
All other chemicals were purchased from either Sigma or Fluka
(Buchs, Switzerland).
2.2. Cloning and plasmids
pEYFP-Mito and pECFP-Mito were purchased from Clontech
(Palo Alto, CA, USA). To generate pTRE-ECFP-Mito, the eCFP-
Mito coding sequence was subcloned by polymerase chain reaction
(PCR) and inserted into the EcoRI site of pTRE (Clontech). pCI HA-
Drp1(K38A) was constructed by PCR subcloning of the Drp1(K38A)
coding sequence from pcDNA3-HA-Drp1(K38A) (gift from A. Van
der Bliek) into the EcoRI/XbaI site of pCI (Promega, Madison, WI,
USA). During the PCR subcloning, we added an alternative HA tag
(MQDLPGNDNSTAGL) to the N-terminal end of Drp1(K38A).
pCI-HA-FisFL was produced by amplifying the cDNA of hFis1
from a human liver cDNA library (Serono, Switzerland) and subclon-
ing the PCR product into the EcoRI/XbaI site of pCI. During the
PCR subcloning, we added an HA tag (as above) to the N-terminal
end of hFis1 (for further information see James et al., submitted). All
PCRs were performed with Pwo or Tgo polymerase (Roche, Rot-
kreuz, Switzerland), the clones were veri¢ed by DNA sequencing.
2.3. Cell culture and transfections
HeLa and Madin^Darby canine kidney (MDCK) Tet-O¡ cells
(Clontech) were cultured at 37‡C in a humidi¢ed incubator in the
presence of 5% CO2/95% air, in DMEM high glucose supplemented
with 10% fetal calf serum, 2 mM glutamine, 50 U/ml penicillin and 50
Wg/ml streptomycin. G418 was added to MDCK Tet-O¡ cells accord-
ing to the manufacturer’s instructions. Cells were transfected with
either calcium phosphate according to Jordan et al. [23] or Fugene
according to the manufacturer’s instructions (Roche). MDCK Tet-O¡
cells with eCFP targeted to mitochondria (mtCFP) stably transfected
(MMCS) were obtained by co-transfection of pTRE-eCFP-mito and
pTK-Hyg (10:1) and selected with hygromycin (400 Wg/ml) in the
presence of tetracycline (1 Wg/ml) to keep o¡ mtCFP expression.
HeLa cells stably transfected with mtYFP tet-inducible (HMYS)
were obtained by co-transfection of pTRE-eYFP-mito and pTet-O¡.
The cells were then selected with G418 (800 Wg/ml) in the presence of
tetracycline (1 Wg/ml) and individual £uorescent clones were selected
by £uorescence-activated cells sorting.
2.4. Cell fusion
For cell fusion experiments, MMCS and HMYS cells were culti-
vated for 4 days before experiment without tetracycline to induce
mtCFP or mtYFP expression respectively. Twenty-four hours before
fusion MMCS were plated to 70% con£uence in individual glass bot-
tom dishes (3 cm dishes, MaTek, MA, USA). Four hours before cell
fusion HMYS or transiently transfected HeLa cells were plated (70%
con£uence) in the same dishes. They were allowed 3 h to attach then
cycloheximide was added to a ¢nal concentration of 50 Wg/ml; the
cells were then left for another hour. To fuse cells, we treated them
with a mix of prewarmed 50% w/v polyethylene glycol (PEG) 6000/
DMEM for 2^3 min at 37‡C (this is a modi¢cation of a protocol
described in [24]). The cells were then washed gently four times with
phosphate-bu¡ered saline and placed back in culture medium with
cycloheximide. The cells were observed 1^24 h post fusion. To assess
cell fusion in certain experiments, we transfected HMYS cells with
pDsRed1 (Clontech), which drives expression of a red £uorescent
cytosolic protein. The presence of blue mitochondria in a cell with
red cytosolic £uorescence was indicative of a fusion between MMCS
and HMYS cells. Cells observed 24 h after cell fusion were treated
with the pan-caspase inhibitor zVAD (100 WM) to prevent cell death
due to cycloheximide treatment.
2.5. Drug treatments and activity assays
To disrupt the tubulin network we treated cells with nocodazole (5
Wg/ml). To cause forced polymerization of the tubulin network we
treated cells with taxol (1 WM). To cause impairment of the actin
network, we treated cells with 10 WM cytochalasin D. To disrupt
mitochondrial inner membrane potential, we treated cells with 75
WM or 10 WM cccp.
To inhibit protein synthesis during our experiments we added cyclo-
heximide (50 Wg/ml) to cell culture media 1 h prior to fusion. In order
to ensure arrest of protein synthesis, we performed a fusion experi-
ment adding radiolabeling medium after fusion (DMEM Cys and Met
were replaced by 35S-labeled Cys and Met, Amersham). Cells were
collected at di¡erent times after fusion by resuspending them in
1Usample bu¡er (10% glycerol, 2.0% SDS, 10 mM EDTA, 60 mM
Tris, 100 mM dithiothreitol, 0.05% bromophenol blue). Samples were
centrifuged through glass wool to break genomic DNA, heated and
loaded on a 12% SDS^PAGE gel. The gel was stained with Coomassie
blue to ensure equal loading of samples and dried and autoradio-
graphed.
If not speci¢ed otherwise, all drugs were added 1 h before fusion
and kept in cell culture medium after fusion. Concentrated stocks of
drug were made in dimethylsulfoxide, ethanol or methanol, they were
freshly diluted in medium before each experiment, ¢nal solvent con-
centration never exceeded 0.1%.
2.6. Quantitative analysis of the fusion process
To analyze the fusion process quantitatively, we estimated in each
polykaryon the percentage of mtYFP-labeled mitochondria that con-
tained mtCFP, those were considered fused. Since precise determina-
tion of percentage is di⁄cult, we divided the polykarya into the ¢ve
following categories: 0^20%, 21^40%, 41^60%, 61^80%, 91^100%. We
determined the percentage of fused mitochondria in cells ¢xed at a
given time after fusion.
2.7. Fluorescence and live microscopy
We used an inverted microscope (Axiovert 135TV, 100U objective,
Zeiss) equipped with a 50 W Hg lamp which allowed us to visualize
living cells on glass bottom dishes. To achieve complete separation of
eCFP and eYFP £uorescence, we used the following ¢lter set: CFP
set: excitation ¢lter D414/30U, beam splitter 455 DCLP, emission
¢lter HQ 487/15U ; YFP set: excitation ¢lter HQ500/14U, beam
splitter 51017bs (Chroma, USA), emission ¢lter 51017 m (Chroma).
For confocal microscopy, we used a Zeiss inverted 200M micro-
scope with a scanhead QLC100 Nipkow disk (Yokogawa) equipped
with a three line argon laser 457/488/514 (Laser Physics) with AOTF
control of laser lines (Visitech). We took pictures with a Coolsnap HQ
Camera (Roper Scienti¢c). Image acquisition and analysis was per-
formed with Metamorph/Meta£uor 4.1.2 software (Universal Imag-
ing).
For video microscopy, we used a Zeiss Axiovert S1000TV £uores-
cence microscope, a 50 W Hg lamp attenuated by transmission neu-
tral-density ¢lters (Omega Optical, Brattleboro, VT, USA), a CCD
camera C4742-95-12NRB (Hamamatsu-City, Japan) and Open Lab
Software (Improvision, Coventry, UK). The temperature (37‡C) and
atmosphere (5% CO2) control was done with the CTI-3700/37-2-Dig-
ital system (PeCon, Erbach-Bach, Germany). Exposure time: 200^300
ms; delay between pictures: 30 s; recording time: 15 min; frames/s: 2.
For some experiments we replaced standard DMEM by DMEM
without phenol red. Pictures were processed in Adobe Photoshop 6.0
or converted into QuickTime movies using Open Lab.
3. Results
3.1. Mitochondria fuse and mix their matrix contents
To investigate mitochondrial fusion, we decided to fuse two
cell lines, MDCK and HeLa, each displaying mitochondria
labeled either with eCFP (MDCK) or with eYFP (HeLa).
Both cell lines expressed the eCFP or eYFP genes under the
control of a Tet-responsive promoter. We chose an inducible
promoter to avoid continuous expression of these proteins,
which appeared to be deleterious for the cells. The £uorescent
proteins were targeted to the matrix space of the mitochon-
dria. Upon fusion of the two cell types, we analyzed mito-
chondria for the presence of one or both £uorescent proteins.
Mitochondria that displayed both eYFP and eCFP were con-
sidered to result from a fusion between eCFP- and eYFP-
labeled mitochondria. We fused the cells with the addition
of PEG-saturated medium for 2^3 min. In some experiments,
cell fusion was detected by the di¡usion of a cytosolic marker,
the protein DsRed, that was transiently expressed in HeLa
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cells only (Fig. 1A, DsRed1). Moreover, formation of poly-
karya was easily observed by phase contrast microscopy and
was indicative of cell fusions. The ¢rst mitochondria that ap-
peared to display both £uorescences (eYFP+eCFP) were de-
tected as soon as 90 min after PEG addition and were clearly
observed at 2^4 h post cell fusion (Fig. 1A,B). At 6 h post cell
fusion, a large part of the polykarya had all of their mito-
chondria labeled with both £uorescent proteins; however, the
distribution of the proteins was still di¡erent. A complete
mitochondrial fusion, which means that both proteins are
homogeneously distributed throughout the polykaryon mito-
chondria, was observed 24 h after cell fusion (Fig. 1C).
To exclude the possibility that bilabeled mitochondria re-
sulted from the superposition of two di¡erently colored mito-
chondria, confocal microscopy was used. We performed the
recording on a single focal plan that allowed us to have a z
resolution of 1 Wm, which is almost the width of a standard
mitochondrion (Fig. 1D). This result con¢rmed that eYFP
and eCFP were localized to only one mitochondrion, suggest-
ing that fusion of mitochondria was responsible for this co-
localization. However, this co-localization could have resulted
from the import of de novo synthesized eYFP or eCFP to
mitochondria already containing either of these proteins.
However, this hypothesis is unlikely since the cells were
Fig. 1. Mitochondria fuse and mix their matrix content. A: MMCS cells fused with HMYS cells pictured 4 h after fusion. MtCFP picture: mi-
tochondria from the MMCS cell; mtYFP picture: mitochondria from the HMYS cell ; DsRed picture: the red £uorescent protein, transiently
expressed in HMYS cell, has di¡used in the MMCS cells; merge of mtCFP (red) and mtYFP (green) images: fused mitochondria appear in yel-
low. B: Higher magni¢cation of the boxed area in A merge. C: Twenty-four hours after fusion in polykarya, all mitochondria have fused. D:
Confocal image taken 3 h after fusion of a MMCS cell (right part of the picture) with a HeLa cell transiently transfected with mtYFP (left
part of the picture); this represents a single plane image with a z resolution of 1 Wm; overlay with arti¢cial color, as described above. Scale
bar 10 Wm.
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treated with 50 Wg/ml cycloheximide 1 h before fusion to in-
hibit protein synthesis. This treatment was shown to inhibit
e⁄ciently protein synthesis (data not shown).
To further con¢rm that mitochondrial fusion was occur-
ring, we performed video microscopy recording of fused cells
1 h following PEG treatment. We observed mitochondria
moving in the cell and eventually fusing, events that resulted
in the mixing of eCFP and eYFP. This observation unambig-
uously proved mitochondrial fusion (see supplemental data).
3.2. Mitochondrial fusion occurs in cells displaying an
abnormal actin or tubulin network
Since mitochondria have been reported to move on either
actin or microtubule networks depending on cell type and/or
cell compartments, we investigated if we could impair mito-
chondrial fusion by altering these networks. Treatment of cells
with 5 WM nocodazole 1 h before fusion completely disrupted
the microtubule network (assayed with an antibody against
L-tubulin, data not shown) and modi¢ed the mitochondrial
morphology (Fig. 2, nocodazole). However, disruption of the
microtubule network did not prevent mitochondrial fusion
(Fig. 2, nocodazole). Forcing microtubule polymerization
with taxol treatment (1 WM) 1 h before fusion a¡ected the
microtubule network and cell morphology but did not prevent
mitochondrial fusion (Fig. 2, taxol).
We also investigated if disruption of the actin network
could inhibit mitochondrial fusion. We used cytochalasin D
(10 WM), which has three major primary e¡ects in vitro: cap-
ping of the barbed end of the actin ¢lament, disrupting the
supramolecular organization of actin ¢laments and promoting
depolymerization of ¢laments undergoing rapid length change
(con¢rmed by actin staining with TRITC-phalloidin, data not
shown, see also [25]). Firstly, we observed that treating the
cells with this drug 1 h before fusion had a considerable e¡ect
on both the cellular and mitochondrial morphology (data not
shown). The mitochondrial fusion took place but the process
seemed to be slowed down. Most of the fused mitochondria
were found near the site at which the cell membranes fused
(Fig. 2, cytochalasin D). Quantitative experiments con¢rmed
that mitochondrial fusion was signi¢cantly slowed down. Re-
sults from three independent fusion experiments show that 3 h
after fusion, in cytochalasin D-treated cultures, 63% of the
polykarya (n=30) have less than 20% of their yellow mito-
chondria fused whereas in control cells 89% of the polykarya
6
Fig. 2. E¡ect of cytoskeleton alteration, Drp1K38A or hFis1p overexpression on mitochondrial fusion. Cells treated with: nocodazole (5 WM),
note the change in mitochondrial morphology; taxol (5 WM) and cytochalasin D (10 WM), note the reduced number of fused mitochondria (ar-
row indicates two fused mitochondria). Nocodazole- and taxol-treated cells were pictured 4 h after cell fusion, cytochalasin D 3 h after cell fu-
sion. Cells overexpressing: hFis1, note the fragmentation of mitochondria induced by expression of the protein; Drp1K38A, note intercon-
nected mitochondria induced by expression of the protein. Cells were pictured 4 h after cell fusion. Scale bar 10 Wm.
Fig. 3. E¡ect of vim disruption on mitochondrial fusion. A: Cells treated with 75 WM cccp. Note the absence of mitochondrial fusion in a
polykaryon resulting from the fusion of two MMCS cells (left and right side) and one HMYS cell (in the middle). The fusion of the three cells
is con¢rmed by the di¡usion in the MMCS cells of DsRed1 protein transiently expressed in the HMYS cell. B: Higher magni¢cation of the
boxed area in A. Cells were pictured 2 h after cell fusion. Scale bar 10 Wm.
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(n=28) had more than 20% of their yellow mitochondria
fused.
3.3. Fragmented or elongated mitochondria are still able to fuse
It is well accepted that a balance between fusion and ¢ssion
events is necessary to maintain mitochondrial morphology.
However, it is not clear if there is a cross-talk between these
two processes. We tested whether fusion of mitochondria was
stimulated when one of the cell types used contained frag-
mented mitochondria. In yeast, mitochondrial ¢ssion is medi-
ated through Fis1p, a protein essential for mitochondrial ¢s-
sion [26]. In this study, we obtained mitochondrial ¢ssion by
overexpressing hFis1, the mammalian homologue of Fis1p
(James et al., submitted). Following fusion of cells transfected
with hFis1 with cells displaying mitochondria with a normal
morphology, we found that mitochondrial fusion was not ac-
celerated compared to the kinetics of mitochondrial fusion
occurring in cells displaying normal mitochondria (Fig. 2,
hFis1).
We also tested whether mitochondrial fusion was reduced
when one of the cell types displayed interconnected mitochon-
dria. Drp1(K38A), a dominant negative mutant of Drp1, a
protein known to play a role in mitochondrial ¢ssion, was
overexpressed in order to obtain an interconnected mitochon-
drial network. Mitochondrial fusion was not reduced by over-
expression of the Drp1 mutant (Fig. 2, Drp1(K38A)).
3.4. Mitochondrial fusion requires an intact mitochondrial
membrane potential
Treatment of cells with cccp, a protonophore that disrupts
the mitochondrial membrane potential (vim) and uncouples
oxidative phosphorylation, leads to mitochondrial fragmenta-
tion ([26] and our unpublished data). We wondered if this
e¡ect resulted from impaired fusion of mitochondria rather
than ¢ssion. Cells were treated with 75 WM cccp, a concentra-
tion that completely disrupts the vim, for 1 h. The vim dis-
ruption was con¢rmed using TMRE (40 nM), a mitochondrial
staining dye whose accumulation in the matrix is dependent
on vim (data not shown). In fused cells 2 h after cytoplasmic
fusion, mitochondria were fragmented and no mitochondrial
fusion was observed (Fig. 3A,B). At later time points (12 h),
fused cells displayed mixed unicolor-labeled mitochondria but
no mitochondria displayed both colors indicating that no mi-
tochondrial fusion occurred in cells treated with cccp (data
not shown).
4. Discussion
Since their discovery, mitochondria have been described as
organelles able to change their shape through fusion and ¢s-
sion events [16]. Nevertheless, if the dynamic nature of the
mitochondria and their ability to fuse and divide has been
clearly established in di¡erent eukaryotes [6,8], the fusion of
mammalian mitochondria still remains a matter of debate
[27]. One of the problems encountered when mitochondria
are observed by light microscopy or £uorescence microscopy
using a single £uorescent mitochondrial marker is to distin-
guish between fusion events and transient contacts between
mitochondria. In our study, we developed an assay based
on the mixing of two £uorescent proteins in the mitochondrial
matrix. This procedure allowed us to clearly show that mito-
chondrial merging does occur in mammalian cells and is com-
pleted in less than 24 h. So it could be said that this process is
fast compared to the time needed for functional complemen-
tation; restoration of normal morphology and respiratory ac-
tivities in hybrids of two respiration-de¢cient cell lines follow-
ing fusion required more than 10 days [21]. However,
mitochondrial merging is clearly slower than the di¡usion of
the cytosolic protein DsRed1. Our data are consistent with
recent data published by Legros et al. [28] and with the ob-
servation that mitochondrial DNA from wild type cytoplasts
spreads throughout mitochondria from b0 cells within 6 h
after fusing the cells [29].
Our results also shed some light on the mechanism of the
fusion process. Studies on a number of cell types showed that
mitochondria co-localize with microtubules, actin micro¢la-
ments and intermediate ¢laments [5]. Depending on the cell
type, they can be transported across the cytoplasm using both
microtubule-based [30^33] and actin-based motors [31,34^37].
Yet our results clearly show that the mitochondrial fusion
process in itself is independent of both actin and microtubule
cytoskeleton. However, we consistently observed that follow-
ing actin disruption, the kinetics of mitochondrial fusion was
signi¢cantly slowed down. At 3 h post cell fusion, the percent-
age of fused mitochondria rarely exceeded 20% when cytocha-
lasin D was added to the cultures, whereas in its absence,
more than 50% of mitochondria had fused. Because cytocha-
lasin D triggers cell detachment, we have not been able to
monitor mitochondrial fusion later than 5 h after actin de-
polymerization. In cells treated with cytochalasin D, the mo-
bility of mitochondria was clearly altered and we think that
this could be responsible for a decrease in the probability that
two mitochondria meet and fuse. In contrast to cytochalasin
D, agents that destabilize microtubules did not modify the
kinetics of mitochondrial fusion, suggesting that actin, more
than microtubules, is required for the mobility of mitochon-
dria in those mammalian cells.
Importantly, we found that an intact vim is required for
mitochondrial fusion to occur, since decreasing vim with cccp
resulted in a rapid ¢ssion of mitochondria and absence of
mitochondrial fusion. This result is in agreement with the
results recently published by Legros et al. [28]. The mecha-
nism by which the vim would permit mitochondrial fusion is
unclear and is currently being investigated.
Studies in yeast suggested that mitochondrial fusion is of
particular importance in the inheritance and maintenance of
the mitochondrial genome [38]. Another role of this process
would be to allow complementation of mitochondrial gene
products, as recently shown in mammals [21,22]. Mitochon-
dria have also been proposed to be interconnected and there-
by form an electrically united system that would facilitate
energy distribution throughout the cell [39]. Mitochondrial
fusion and ¢ssion might also play a role in other physiological
process such as apoptosis ([2,7] and James et al., submitted).
Our results on the rapid kinetics of mitochondrial fusion sup-
port the hypothesis where mitochondria are considered as a
single functional unit [27,37].
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